Posted in M&A / Deals Ambrosia adds a megaround for obesity drugs April 1, 2026 BioPharma Dive The $100 million Series B round will be used to bring the biotech s oral GLP-1 into early human testing. M&A / DealsMetabolic & GLP-1Read full story